| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 09/17/1998 | WO1998040403A1 Psca: prostate stem cell antigen |
| 09/17/1998 | WO1998040401A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 09/17/1998 | WO1998040394A1 Vector constructs for the selection and identification of open reading frames |
| 09/17/1998 | WO1998040099A1 Leptospira pathogens |
| 09/17/1998 | WO1998040089A1 Recombinant vasoactive protein from salivary gland of the black fly |
| 09/17/1998 | WO1998040049A2 Specific magnetosome, method for the production and use thereof |
| 09/17/1998 | WO1998039974A2 A biocontrol agent containing an endotoxin gene |
| 09/17/1998 | WO1998039973A1 Bionematicide with efficient ovicide activity against plant-parasitic nematodes |
| 09/17/1998 | WO1998024905A3 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | DE19708774A1 Nucleinsäuremoleküle codierend Enzyme die Fructosylpolymeraseaktivität besitzen Nucleic acid molecules encoding enzymes have the Fructosylpolymeraseaktivität |
| 09/17/1998 | CA2284518A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | CA2283746A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 09/17/1998 | CA2283678A1 28 human secreted proteins |
| 09/17/1998 | CA2283624A1 Leptospira pathogens |
| 09/17/1998 | CA2283296A1 Growth factor receptor binding protein |
| 09/17/1998 | CA2282809A1 Cytochrome p450 monooxygenases |
| 09/17/1998 | CA2282807A1 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 09/17/1998 | CA2281914A1 Pesticidal bacillus thuringiensis strains |
| 09/17/1998 | CA2232751A1 Novel compounds |
| 09/16/1998 | EP0864649A2 Method for obtaining recombinant surface antigen of hepatitis B virus (HEP B) of higher immunogenic capacity and use thereof in a vaccine preparation |
| 09/16/1998 | EP0864584A1 Lipopetide from Actinoplanes sp. with pharmacological properties, process for its preparation and its use |
| 09/16/1998 | EP0863993A1 Method of screening anti-amebic agents |
| 09/16/1998 | EP0863991A1 Antigenic preparations |
| 09/16/1998 | EP0863989A2 Improved process for the production of semi-synthetic cephalosporins via expandase activity on penicillin g |
| 09/16/1998 | EP0863986A1 Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same |
| 09/16/1998 | EP0863981A1 Detection, prevention and treatment of papillomatous digital dermatitis |
| 09/16/1998 | EP0699442B1 Use of a strain of the fungus fusarium as a producer of substances and a preparation based on said substances with adaptogenic and immunomodulating properties |
| 09/16/1998 | EP0661930B1 Viscous liquid xylitol compositions and method for preparing same |
| 09/16/1998 | CN1193356A Riboflavin-production process by means of micro-organisms with modified isocitratlyase activity |
| 09/16/1998 | CN1193354A 质粒 Plasmid |
| 09/16/1998 | CN1193352A Human chitinase, its recombinant production, its use for decomposing chitin, and its use in therapy or prophylaxis against infection diseases |
| 09/16/1998 | CN1193350A Antigen non-specific glycosylation inhibiting factor derivatives |
| 09/16/1998 | CN1193348A Enzymes and micro-organisms with amidase activity for hydrolysing polyamides |
| 09/16/1998 | CN1193347A Enzymes and microorganisms having amidase activity for hydrolysing polyamides |
| 09/16/1998 | CN1193346A Modified enzyme with lipolytic activity |
| 09/16/1998 | CN1193343A Process for producing L-glutamic acid by fermentation method |
| 09/16/1998 | CN1193278A Chemical compounds |
| 09/16/1998 | CN1193048A Method for producing beta-carotene by fermentation |
| 09/15/1998 | US5808034 Genetic engineering |
| 09/15/1998 | US5808031 Human gene associated with arrest of cell growth and dna damage induction; diagnosis and treatment of cancer |
| 09/15/1998 | US5808029 Genetic engineering |
| 09/15/1998 | US5808012 Protein-enriched thermoplastics |
| 09/15/1998 | US5808007 Treating cell proliferative or immunologic disorders |
| 09/15/1998 | US5808001 Human ice homolog antibodies and compositions thereof |
| 09/15/1998 | US5807996 Fused polypeptides comprising interleukin-4 polypeptide fragments |
| 09/15/1998 | US5807988 Isolation, characterization, and use of the human and subunit of the high affinity receptor for immunoglobulin E |
| 09/15/1998 | US5807980 Bovine pancreatic trypsin inhibitor derived inhibitors of factor VIIa-tissue factor complex |
| 09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
| 09/15/1998 | US5807823 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 09/15/1998 | US5807740 Regulators of UCP2 gene expression |
| 09/15/1998 | US5807736 Method for biodegradation of aromatic and chlorinated compounds using microorganism strain FERM BP-5102 |
| 09/15/1998 | US5807734 Polypeptide |
| 09/15/1998 | US5807729 Isolated nucleic acid |
| 09/15/1998 | US5807726 Nucleic acids encoding dog gastric lipase and their use for the production of polypeptides |
| 09/15/1998 | US5807725 Long-chain prenyl diphosphate synthase |
| 09/15/1998 | US5807723 Homologously recombinant slow growing mycobacteria and uses therefor |
| 09/15/1998 | US5807712 Genetic engineered protein |
| 09/15/1998 | US5807710 Nucleic acids encoding stable mutants of D-N-α-carbamoylase |
| 09/15/1998 | US5807702 Genetic engineering |
| 09/15/1998 | US5807700 Method of screening anti-amebic agents with an E. coli mutant having a deleted adhE gene complemented by the E. histolytica EhADH2 gene |
| 09/15/1998 | US5807689 Bioanalysis |
| 09/15/1998 | US5807680 Genetic engineering; cloning inserts; transformation, transcription; polymerase chain reactions; drug screening; medical diagnosis |
| 09/15/1998 | US5807546 Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria |
| 09/13/1998 | CA2231899A1 Plant-containing composition |
| 09/11/1998 | WO1998039487A1 Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication |
| 09/11/1998 | WO1998039460A1 Nucleic acid molecules from artichoke ($i(cynara scolymus)) encoding enzymes having fructosyl polymerase activity |
| 09/11/1998 | WO1998039459A1 PROMOTERS OF THE GENES GLUTAMATE DESHYDROGENASE, β-N-ACETYLHEXOSAMINIDASE AND $b(g)-ACTINE, AND THEIR USE IN SYSTEMS OF EXPRESSION, SECRETION AND ANTI-SENS IN FILAMENTARY FUNGI |
| 09/11/1998 | WO1998039458A1 Process for preparing doxorubicin |
| 09/11/1998 | WO1998039452A1 Dna fragments containing biotin biosynthetase gene and use of the same |
| 09/11/1998 | WO1998039451A1 Feline immunodeficiency virus clone jsy3 |
| 09/11/1998 | WO1998039450A2 SURFACE PROTEIN (SPsA PROTEIN) OF STREPTOCOCCUS PNEUMONIAE, DELETED DERIVATIVES, EXPRESSION SYSTEM FOR SAID PROTEINS AND VACCINE SYSTEM WITH SAID PROTEINS |
| 09/11/1998 | WO1998039448A9 186 human secreted proteins |
| 09/11/1998 | WO1998039448A2 186 human secreted proteins |
| 09/11/1998 | WO1998039446A2 70 human secreted proteins |
| 09/11/1998 | WO1998039442A1 Human mitochondrial membrane protein |
| 09/11/1998 | WO1998039441A1 Human chemokine receptor-like chemokine |
| 09/11/1998 | WO1998039440A2 CALCIUM INDEPENDENT RECEPTOR OF α-LATROTOXIN, CHARACTERIZATION AND USES THEREOF |
| 09/11/1998 | WO1998039436A2 Fibroblast growth factor mutein compositions and methods of use therefor |
| 09/11/1998 | WO1998039435A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
| 09/11/1998 | WO1998039433A1 Complement receptor type 1 (cr1)-like sequences |
| 09/11/1998 | WO1998039432A1 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
| 09/11/1998 | WO1998039430A1 Methods and compositions for diagnosis and treatment of cancer |
| 09/11/1998 | WO1998039424A1 Dna encoding pneumocystis carinii protease |
| 09/11/1998 | WO1998039411A1 Adenovirus e1-complementing cell lines |
| 09/11/1998 | WO1998039410A1 IλB $i(KINASES) |
| 09/11/1998 | WO1998039361A1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof |
| 09/11/1998 | WO1998039031A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/11/1998 | WO1998031795A3 Novel human metallothionein |
| 09/11/1998 | WO1998030692A3 Human endosulfine gene |
| 09/11/1998 | WO1998030687A3 Protein containing an srcr domain |
| 09/11/1998 | WO1998030584A3 Secreted proteins and polynucleotides encoding them |
| 09/11/1998 | WO1998029536A3 Reversibly inactive synthetic beta-galactosidase |
| 09/11/1998 | WO1998029438A3 Cortistatin polypeptides |
| 09/11/1998 | WO1998028424A3 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| 09/11/1998 | WO1998025956A3 Human GTP-binding proteins |
| 09/11/1998 | CA2284131A1 70 human secreted proteins |
| 09/11/1998 | CA2284078A1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof |
| 09/11/1998 | CA2283394A1 Methods and compositions for diagnosis and treatment of cancer |
| 09/11/1998 | CA2283379A1 Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication |
| 09/11/1998 | CA2283299A1 186 human secreted proteins |